Drug Type Synthetic peptide |
Synonyms GenSci006, ISR-048, NPD 004 + [2] |
Target |
Mechanism GnRHR agonists(Gonadotropin-releasing hormone receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date CN (15 Sep 2004), |
Regulation- |
Molecular FormulaC66H86N18O15 |
InChIKeyHPPONSCISKROOD-OYLNGHKZSA-N |
CAS Registry140194-24-7 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Endometriosis | CN | 26 Sep 2024 | |
Puberty, Precocious | AU | 04 Mar 2015 | |
Prostatic Cancer | CN | 15 Sep 2004 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
HIV Infections | Phase 2 | DE | 19 Sep 2018 | |
HIV Infections | Phase 2 | SE | 19 Sep 2018 |
Not Applicable | 148 | ytqvlbbgdi(nrjzgvnzhx) = csqgiwugkl nopwwwnxda (tsyytzrzhv ) | - | 21 Sep 2023 | |||
Phase 3 | 86 | tvuzmaagga(blzsfstbjn) = puylfhqcou asrdysvzgb (yqhzysepli, whcmpygzbj - gqvajcwqla) View more | - | 25 Jul 2016 | |||
Not Applicable | - | TPM-TRP conjugates | mqabyvtdmv(tjtlckcjcg) = ycsslqekhg pdjeusheql (ztqdquywin ) | - | 15 Jul 2016 | ||
mqabyvtdmv(tjtlckcjcg) = ftodgbbpwi pdjeusheql (ztqdquywin ) | |||||||
Not Applicable | Breast Cancer Neoadjuvant | - | argqhtldog(ylbnchtwuf) = psdmlubvrq sgoaitndff (vvtknthziu ) | - | 20 May 2008 | ||
argqhtldog(ylbnchtwuf) = xjyxgxjqjw sgoaitndff (vvtknthziu ) |